Deltagen is a startup based in San Mateo, the United States, most recent round IPO, 1 tracked investor.
Based in San Mateo, the United States, Deltagen is a startup founded in 2017. Its most recent tracked round is IPO. Brouky records 1 investor associated with the company.
Deltagen is a biotechnology company focused on drug discovery through genomics and genetics. They aim to develop new therapeutics by identifying and validating novel drug targets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.